MEDGENICS INC - COM NEW (MDGN)

CUSIP: 58436Q203

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM NEW
Total 13F shares
2,221,464
Share change
+237,909
Total reported value
$15,423,253
Price per share
$6.98
Number of holders
27
Value change
+$1,718,958
Number of buys
16
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 58436Q203?
CUSIP 58436Q203 identifies MDGN - MEDGENICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MEDGENICS INC - COM NEW (MDGN) as of Q1 2014

As of 31 Mar 2014, MEDGENICS INC - COM NEW (MDGN) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,221,464 shares. The largest 10 holders included Legal & General Group Plc, BAILLIE GIFFORD & CO, Belmont Global Advisors, Inc., VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BRIDGEWAY CAPITAL MANAGEMENT INC, PERCEPTIVE ADVISORS LLC, LPL Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY. This page lists 27 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.